User:Mjoyced14/sandbox


 * 1) REDIRECT Impel neuropharma

Impel NeuroPharma, Inc. is a Seattle, Washington based biotechnology/pharmaceutical company specializing in transporting pharmaceuticals into the brain via intranasal delivery, therefore bypassing the blood-brain barrier. Impel NeuroPharma’s Precision Olfactory Delivery (POD) device technology is specifically designed to deposit a majority of drug on the olfactory region of the nasal cavity.

Impel NeuroPharma was founded by Dr. John Hoekman, Ph.D. and Michael Hite in 2008 after the technology was originally tested for research at the University of Washington.